Cost-effectiveness analysis of treatments to reduce cholesterol concentration, blood pressure and smoking for the prevention of coronary heart disease

被引：0

作者：

Plans-Rubió, P ^{[1
]}

机构：

[1] Dept Sanitat Catalonia SCS, Barcelona, Spain

来源：

VALUE IN HEALTH | 2002年 / 5卷 / 06期

关键词：

D O I：

10.1016/S1098-3015(10)61288-0

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：484 / 484

页数：1

共 50 条

[1] Cost-effectiveness analysis of treatments to reduce cholesterol levels, blood pressure and smoking for the prevention of coronary heart disease - Evaluative study carried out in Spain
Plans-Rubio, P
PHARMACOECONOMICS, 1998, 13 (05) : 623 - 643
[2] Cost-Effectiveness Analysis of Treatments to Reduce Cholesterol Levels, Blood Pressure and Smoking for the Prevention of Coronary Heart DiseaseEvaluative Study Carried Out in Spain
Pedro Plans-Rubió
PharmacoEconomics, 1998, 13 : 623 - 643
[3] ECONOMICS OF INTERVENTION ON BLOOD CHOLESTEROL FOR CORONARY HEART-DISEASE PREVENTION - EVIDENCE FOR COST-EFFECTIVENESS
RECKLESS, JPD
ATHEROSCLEROSIS, 1989, 79 (01) : 94 - 94
[4] The importance of cholesterol, blood pressure and smoking for coronary heart disease
Lewington, S
EUROPEAN HEART JOURNAL, 2003, 24 (19) : 1703 - 1704
[5] A concise review of the cost-effectiveness of coronary heart disease prevention
Brown, AID
Garber, AM
MEDICAL CLINICS OF NORTH AMERICA, 2000, 84 (01) : 279 - +
[6] Cost-effectiveness of aspirin for the primary prevention of coronary heart disease
Rodondi, Nicolas
Moran, Andrew
Coxson, Pamela G.
Lightwood, James
Williams, Lawrence W.
Cornuz, Jacques
Goldman, Lee
CIRCULATION, 2006, 114 (18) : 827 - 827
[7] Cost-effectiveness analysis for statin therapies in the primary prevention of coronary heart disease in Italy
Berto, P
Munro, V
Gaddi, A
Negrini, C
Hutton, J
Mast, O
CLINICAL DRUG INVESTIGATION, 2000, 20 (02) : 109 - 121
[8] Cost-Effectiveness Analysis for Statin Therapies in the Primary Prevention of Coronary Heart Disease in Italy
Patrizia Berto
Vicky Munro
Antonio Gaddi
Cristina Negrini
John Hutton
Oliver Mast
Clinical Drug Investigation, 2000, 20 : 109 - 121
[9] Comparative cost-effectiveness of interventions for the primary prevention of coronary heart disease
Lim, SS
Vos, TE
Begg, S
Liew, D
Peeters, A
McNeil, JJ
CIRCULATION, 2002, 106 (19) : 758 - 759
[10] The cost-effectiveness of the SPHERE intervention for the secondary prevention of coronary heart disease
Gillespie, Paddy
O'Shea, Eamon
Murphy, Andrew W.
Byrne, Mary C.
Byrne, Molly
Smith, Susan M.
Cupples, Margaret E.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (03) : 263 - 271

← 1 2 3 4 5 →